JESSICA ZANGMEISTER: Open Payments
NPI 1154949576 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$331 in 6 payments from 6 companies in 2025. Trend: 2023 $82 · 2024 $670 · 2025 $331
Food & beverage: $331
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| Ipsen Biopharmaceuticals, Inc | 1 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Madrigal Pharmaceuticals | 1 | $23 |
| ABBVIE INC. | 1 | $22 |
| Gilead Sciences, Inc. | 1 | $16 |
Products named: VOQUEZNA, IQIRVO, EOHILIA, REZDIFFRA, Epclusa.
Industry payments across OH — which companies pay providers there.
